Join
Live feed
·
INSIDERFilingvia Quantisnow
ACADIA Pharmaceuticals Inc. logo

PRINCIPAL ACCOUNTING OFFICER Kihara James sold $297,912 worth of shares (11,421 units at $26.08) as part of a pre-agreed trading plan, decreasing direct ownership by 47% to 13,088 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ACAD· ACADIA Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACAD (ACADIA Pharmaceuticals Inc.) and more on Quantisnow.